Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler N Starr

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Biorxiv : the Preprint Server for Biology|December 10, 2020
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Tyler N Starr, Allison J Greaney, Amin Addetia, et al.
Elife|February 21, 2023
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolutionAlief Moulana, Thomas Dupic, Angela M Phillips, et al.
Elife|April 7, 2026
Separating selection from mutation in antibody language modelsFrederick A Matsen, Will Dumm, Kevin Sung, et al.
Science Translational Medicine|June 9, 2021
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infectionAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Molecular Biology and Evolution|August 12, 2025
A Sitewise Model of Natural Selection on Individual Antibodies via a Transformer-EncoderFrederick A Matsen, Kevin Sung, Mackenzie M Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBDAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Nature Communications|November 17, 2022
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1Alief Moulana, Thomas Dupic, Angela M Phillips, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Computational design of an ultrapotent deltacoronavirus miniprotein inhibitorNathan G Avery, Courtney N Yoshiyama, Ashley L Taylor, et al.
Plos Pathogens|June 29, 2022
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopesAllison J Greaney, Rachel T Eguia, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopesAllison J Greaney, Rachel T Eguia, Tyler N Starr, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Biorxiv : the Preprint Server for Biology|December 10, 2020
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Tyler N Starr, Allison J Greaney, Amin Addetia, et al.
Elife|February 21, 2023
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolutionAlief Moulana, Thomas Dupic, Angela M Phillips, et al.
Elife|April 7, 2026
Separating selection from mutation in antibody language modelsFrederick A Matsen, Will Dumm, Kevin Sung, et al.
Science Translational Medicine|June 9, 2021
Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infectionAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Molecular Biology and Evolution|August 12, 2025
A Sitewise Model of Natural Selection on Individual Antibodies via a Transformer-EncoderFrederick A Matsen, Kevin Sung, Mackenzie M Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBDAllison J Greaney, Andrea N Loes, Lauren E Gentles, et al.
Nature Communications|November 17, 2022
Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1Alief Moulana, Thomas Dupic, Angela M Phillips, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2026
Computational design of an ultrapotent deltacoronavirus miniprotein inhibitorNathan G Avery, Courtney N Yoshiyama, Ashley L Taylor, et al.
Plos Pathogens|June 29, 2022
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopesAllison J Greaney, Rachel T Eguia, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2022
The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopesAllison J Greaney, Rachel T Eguia, Tyler N Starr, et al.
Pageof 8